Prospects of elimination of HIV with test-and-treat strategy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 39, 2013, Pages 15538-15543

  Kretzschmar, Mirjam E ^a,b   Schim Van Der Loeff, Maarten F ^c,d   Birrell, Paul J ^e   De Angelis, Daniela ^e   Coutinho, Roel A ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HIV elimination; Mathematical model; Primary HIV infection; Treatment coverage

Indexed keywords

ANAL INTERCOURSE; ARTICLE; BASIC REPRODUCTION NUMBER; COHORT ANALYSIS; DISEASE COURSE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEN WHO HAVE SEX WITH MEN; META ANALYSIS (TOPIC); MORTALITY; PRIMARY INFECTION; PRIORITY JOURNAL; REPRODUCTION; SECONDARY INFECTION; SUSCEPTIBLE POPULATION;

HIV ELIMINATION; MATHEMATICAL MODEL; PRIMARY HIV INFECTION; TREATMENT COVERAGE;

BASIC REPRODUCTION NUMBER; DISEASE ERADICATION; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; PROBABILITY; TIME FACTORS;

EID: 84884603135     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301801110     Document Type: Article

References (45)

1. Velasco-Hernandez JX, Gershengorn HB, Blower SM (2002) Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2(8): 487-493.
2. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373(9657):48-57.
3. Garnett GP, Baggaley RF (2009) Treating our way out of the HIV pandemic: Could we, would we, should we? Lancet 373 (9657) 9-11.
4. Check Hayden E (2010) 'Seek, test and treat' slows HIV. Nature 463(7284):1006.
5. Wagner BG, Kahn JS, Blower S (2010) Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS 24 (5) 775-776.
6. Cambiano V, Rodger AJ, Phillips AN (2011) 'Test-and-treat': The end of the HIV epidemic? Curr Opin Infect Dis 24 (1)19-26.
7. Cohen MS, et al.; HPTN 052 Study Team (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365(6):493-505.
8. Donnell D, et al.; Partners in Prevention HSV/HIV Transmission Study Team (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 375(9731):2092-2098.
9. Montaner JS, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. Lancet 376(9740):532-539.
10. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML (2013) High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339(6122):966-971.
11. Dodd PJ, Garnett GP, Hallett TB (2010) Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 24(5):729-735.
12. Eaton JW, et al. (2012) HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 9(7):e1001245.
13. Walensky RP, et al. (2010) Test and treat DC: Forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Inf Dis. 51(4):392-400.
14. HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (2012) HIV treatment as prevention: Models, data, and questions-towards evidence-based decision-making. PLoS Med 9(7):e1001259.
15. Kretzschmar ME, van der Loeff MF, Coutinho RA (2012) Elimination of HIV by test and treat: A phantom of wishful thinking? AIDS 26 (2) 247-248.
16. Diekmann O, Heesterbeek JA, Roberts MG (2010) The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface 7(47):873-885.
17. van den Driessche P, Watmough J (2002) Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci 180:29-48.
18. CASCADE Collaboration (2000a) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative reanalysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355(9210):1131-1137.
19. CASCADE Collaboration (2000b) Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355(9210):1158-1159.
20. Hollingsworth TD, Anderson RM, Fraser C (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198(5):687-693.
21. MorganD, et al. (2002) HIV-1 infection in rural Africa: Is there a difference inmedian time to AIDS and survival compared with that in industrialized countries? AIDS 2002 16 4 597-597.
22. Todd J, et al. (2007) Time from HIV seroconversion to death: A collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 21(Suppl 6):S55-S63.
23. Diekmann O, Heesterbeek JA, Britton T (2012) Mathematical Tools for Understanding Infectious Diseases Dynamics (Princeton Univ Press, Princeton).
24. Wallinga J, Lipsitch M (2007) How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 274(1609):599-604.
25. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF (1997) Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe. AIDS 11(5):649-662.
26. Gran JM, Wasmuth L, Amundsen EJ, Lindqvist BH, Aalen OO (2008) Growth rates in epidemic models: Application to a model for HIV/AIDS progression. Stat Med 27(23): 4817-4834.
27. Nishiura H (2010) Correcting the actual reproduction number: A simple method to estimate R(0) from early epidemic growth data. Int J Environ Res Public Health 7(1): 291-302.
28. van Griensven GJ, de Vroome EM, Goudsmit J, Coutinho RA (1989) Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 298(6668):218-221.
29. Bezemer D, et al. (2008) A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22(9):1071-1077.
30. van Sighem A, et al.; Swiss HIV Cohort Study (2012) Resurgence of HIV infection among men who have sex with men in Switzerland: Mathematical modelling study. PLoS ONE 7(9):e44819.
31. Birrell PJ, et al. (2013) HIV incidence in men who have sex with men in England and Wales 2001-10: A nationwide population study. Lancet Infect Dis 13(4):313-318.
32. Bello G, et al. (2007) Demographic history of HIV-1 subtypes B and F in Brazil. Infection, genetics and evolution. Infect Genet Evol 7(2):263-270.
33. Salemi M, de Oliveira T, Ciccozzi M, Rezza G, Goodenow MM (2008) High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS ONE 3(1):e1390.
34. Robbins KE, et al. (2003) U.S. Human immunodeficiency virus type 1 epidemic: Date of origin, population history, and characterization of early strains. J Virol 77(11): 6359-6366.
35. Yusim K, et al. (2001) Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution. Philos Trans R Soc Lond B Biol Sci 356(1410):855-866.
36. Walker PR, Pybus OG, Rambaut A, Holmes EC (2005) Comparative population dynamics of HIV-1 subtypes B and C: Subtype-specific differences in patterns of epidemic growth. Infection, genetics and evolution. Infect Genet Evol 5(3):199-208.
37. Alam SJ, et al. (2013) Detectable signals of episodic risk effects on acute HIV transmission: Strategies for analyzing transmission systems using genetic data. Epidemics 5(1):44-55.
38. Romero-Severson EO, Alam SJ, Volz E, Koopman J (2013) Acute-stage transmission of HIV: Effect of volatile contact rates. Epidemiology 24(4):516-521.
39. Mercer CH, et al. (2004) Increasing prevalence of male homosexual partnerships and practices in Britain 1990-2000: Evidence from national probability surveys. AIDS 18(10):1453-1458.
40. Xiridou M, Geskus R, De Wit J, Coutinho R, Kretzschmar M (2003) The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS 17(7):1029-1038.
41. Leung KY, Kretzschmar ME, Diekmann O (2012) Dynamic concurrent partnership networks incorporating demography. Theor Popul Biol 82(3):229-239.
42. Cohen MS, et al. (2012) HIV treatment as prevention: Debate and commentary-will early infection compromise treatment-as-prevention strategies? PLoS Med 9 7 e1001232.
43. WHO. Antiretroviral therapy (ART) coverage among all age groups. Available at www.who.int/gho/hiv/epidemic-response/ART-text/. Accessed November 4, 2012.
44. Volz EM (2012) Complex population dynamics and the coalescent under neutrality. Genetics 190(1):187-201.
45. Kretzschmar M, Gomes MG, Coutinho RA, Koopman JS (2010) Unlocking pathogen genotyping information for public health by mathematical modeling. Trends Microbiol 18(9):406-412.